TY - JOUR
T1 - Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood
AU - Hirsch, Betsy
AU - Shimamura, Akiko
AU - Moreau, Lisa
AU - Baldinger, Shari
AU - Hag-Alshiekh, Maha
AU - Bostrom, Bruce
AU - Sencer, Susan
AU - D'Andrea, Alan D.
PY - 2004/4/1
Y1 - 2004/4/1
N2 - The clinical, cytogenetic, and molecular findings of 2 Fanconi anemia (FA) subtype D1 kindreds, initially identified through a young child with a solid tumor (medullobastoma, Wilms tumor), are described. Each kindred subsequently had a second affected child; one developed Wilms tumor followed by a medulloblastoma, and the other developed T-lineage acute lymphoblastic leukemia. Cytogenetic studies revealed an unusually high spontaneous chromosome aberration rate, contrasting with other FA subtypes. Molecular analysis revealed biallelic BRCA2/FANCD1 mutations. The patients did not exhibit bone marrow failure. Our studies suggest that the D1 subtype represents a severe end of the cytogenetic spectrum within FA, consistent with a critical downstream role of BRCA2 in the FA pathway. Furthermore, this FA sub-group may be preferentially associated with an increased predisposition to solid tumors in early childhood. Recognition of this constellation of findings has significant implications for medical management and genetic counseling of FA families.
AB - The clinical, cytogenetic, and molecular findings of 2 Fanconi anemia (FA) subtype D1 kindreds, initially identified through a young child with a solid tumor (medullobastoma, Wilms tumor), are described. Each kindred subsequently had a second affected child; one developed Wilms tumor followed by a medulloblastoma, and the other developed T-lineage acute lymphoblastic leukemia. Cytogenetic studies revealed an unusually high spontaneous chromosome aberration rate, contrasting with other FA subtypes. Molecular analysis revealed biallelic BRCA2/FANCD1 mutations. The patients did not exhibit bone marrow failure. Our studies suggest that the D1 subtype represents a severe end of the cytogenetic spectrum within FA, consistent with a critical downstream role of BRCA2 in the FA pathway. Furthermore, this FA sub-group may be preferentially associated with an increased predisposition to solid tumors in early childhood. Recognition of this constellation of findings has significant implications for medical management and genetic counseling of FA families.
UR - http://www.scopus.com/inward/record.url?scp=1642315917&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1642315917&partnerID=8YFLogxK
U2 - 10.1182/blood-2003-06-1970
DO - 10.1182/blood-2003-06-1970
M3 - Article
C2 - 14670928
AN - SCOPUS:1642315917
SN - 0006-4971
VL - 103
SP - 2554
EP - 2559
JO - Blood
JF - Blood
IS - 7
ER -